Relief Therapeutics Holding AG (RLFTF)

[ratna1]

Sarcoidosis is a crippling disease!
I recall you posted on it before including the staggering numbers in the world wide market for such a therapeuticum!
This trial is conducted at the University Klinikum of Freiburg which brought Aviptadil back on the map with their publication in the New England Journal of Medicine. They first tried to start this trial 3 years ago but had to abandon it on both safety concerns as well as lack of funding due to Covid 19.. how ironic..
Since ADVITA was founded by the same department before they sold it to RELIEF I wonder wether they use that income to fund the trial or wether RLF is funding it?